-
公开(公告)号:EP0803255A1
公开(公告)日:1997-10-29
申请号:EP95920242.5
申请日:1995-06-02
申请人: TSUMURA & CO.
IPC分类号: A61K37/02 , A61K37/14 , A61K37/24 , A61K37/26 , A61K37/30 , A61K37/43 , A61K37/465 , A61K37/50 , A61K37/54 , A61K37/64 , A61K37/66
CPC分类号: A61K47/183 , A61K9/0019 , A61K38/23 , A61K47/10 , Y10S514/802
摘要: A medicinal composition comprising a peptide as the active ingredient and, as the base, ε-aminocaproic acid or tranexamic acid and a block copolymer of ethylene oxide and propylene oxide represented by the general formula (I): HO(C 2 H 4 O)a-(C 3 H 6 O)b-(C 2 H 4 O)cH, wherein a, b and c represent each an integer of 1 or above. This composition permits the peptide to be highly absorbed by mucous membranes, etc., and the pharmacological effect to be maintained for long.
摘要翻译: 一种药物组合物,其包含作为活性成分的肽和作为碱的ε-氨基己酸或氨甲环酸,以及由通式(I)表示的环氧乙烷和环氧丙烷的嵌段共聚物:HO(C 2 H 4 O)a - (C 3 H 6 O )b-(C 2 H 4 O)c H,其中a,b和c各自表示1以上的整数。 该组合物允许肽被粘膜等高度吸收,药理作用长期保持。